MESOTHELIOMAS PLEURAL
Clinical trials for MESOTHELIOMAS PLEURAL explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMAS PLEURAL trials appear
Sign up with your email to follow new studies for MESOTHELIOMAS PLEURAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Penn medicine launches Triple-Threat attack on deadly mesothelioma
Disease control Recruiting nowThis early-stage study is testing whether adding an immunotherapy drug (pembrolizumab) and special imaging-guided surgery to standard chemotherapy and surgery is safe and effective for treating malignant pleural mesothelioma. The trial will enroll 20 adults with this aggressive c…
Matched conditions: MESOTHELIOMAS PLEURAL
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Light therapy plus immunotherapy: new hope for Tough-to-Treat mesothelioma
Disease control Recruiting nowThis small pilot study is testing whether a two-part treatment is safe and feasible for people with advanced, inoperable mesothelioma that has worsened after standard chemotherapy. First, doctors use a special light therapy during a minimally invasive chest surgery to target canc…
Matched conditions: MESOTHELIOMAS PLEURAL
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New surgical hope for inoperable lung cancer patients
Symptom relief Recruiting nowThis study is testing whether a surgery to remove part of the lung lining can help reduce symptoms and improve quality of life for people with advanced pleural mesothelioma that cannot be fully removed. Researchers will follow 30 participants for about 2 years after surgery to tr…
Matched conditions: MESOTHELIOMAS PLEURAL
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Scientists map mesothelioma tumors to find new treatment paths
Knowledge-focused Recruiting nowThis study aims to better understand the biological makeup of pleural and peritoneal mesothelioma tumors to identify potential new treatment approaches. Researchers will analyze tumor samples from 220 patients to study immune system interactions and genetic patterns. The findings…
Matched conditions: MESOTHELIOMAS PLEURAL
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Apr 01, 2026 20:11 UTC